A phase II study of derdleukin diftitox (Ontak (R)) with CHOP chemotherapy in patients with newly-diagnosed aggressive T-cell lymphomas, the CONCEPT trial: Interim analysis. Foss, F. M., Sjak-Shie, N., Goy, A., Advani, R., Jacobsen, E., Acosta, M. AMER SOC HEMATOLOGY. 2006: 696A–697A

View details for Web of Science ID 000242440003251